15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach
Publication in refereed journal


Times Cited
Web of Science10WOS source URL (as at 15/01/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractObjective: To report the recurrence, progression and survival in patients with T1G3 transitional cell carcinoma (TCC) of the urinary bladder treated with sequential intravesical bacillus Calmette-Guerin (BCG) and chemotherapeutic agents (doxorubicin or epirubicin) on long-term follow up.
All Author(s) ListCheng CW, Chan SFP, Chan LW, Chan CK, Ng CF, Cheung HY, Chan SYE, Wong WS, Lai FMM, Li ML
Journal nameJAPANESE JOURNAL OF CLINICAL ONCOLOGY
Year2004
Month4
Day1
Volume Number34
Issue Number4
PublisherOXFORD UNIV PRESS
Pages202 - 205
ISSN0368-2811
eISSN1465-3621
LanguagesEnglish-United Kingdom
KeywordsBCG vaccine; bladder neoplasms; doxorubicin; epirubicin; transitional cell
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-16-01 at 00:48